×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Oramed Letter to Shareholders
PR Newswire
I am pleased to share with you an update regarding Oramed. Despite the unexpected negative results we received for our U.S. based Phase 3 trial...
2 months ago
Oramed to reinitiate pivotal type 2 diabetes trial after Phase III flop
Clinical Trials Arena
Following a review of the trial data, Oramed discovered that the oral insulin candidate was effective in a particular subset of patients.
2 months ago
Oramed Pharmaceuticals (XTAE:ORMP) Gross Property, Plant and Equipment : ₪5.84 Mil (As of Dec. 2023)
GuruFocus
Oramed Pharmaceuticals (XTAE:ORMP) Gross Property, Plant and Equipment as of today (May 03, 2024) is ₪5.84 Mil. Gross Property, Plant and Equipment...
1 day ago
Oramed Pharmaceuticals (NASDAQ:ORMP) investors are sitting on a loss of 63% if they invested a year ago
Yahoo Finance
Oramed Pharmaceuticals (NASDAQ:ORMP) investors are sitting on a loss of 63% if they invested a year ago ... In this article: ORMP. Investing in...
6 months ago
Oramed Pharmaceuticals (NASDAQ:ORMP) Share Price Crosses Below Two Hundred Day Moving Average of $2.48
MarketBeat
Oramed Pharmaceuticals (NASDAQ:ORMP) Stock Price Crosses Below 200 Day Moving Average of $2.48.
2 days ago
Oramed and HTIT to form joint venture for oral drug products
Pharmaceutical Technology
Oramed Pharmaceuticals and Hefei Tianhui Biotech (HTIT) have entered an agreement to form a joint venture to advance oral drug products.
9 months ago
Oramed and Hefei form oral insulin JV - BioProcess Insider
BioProcess International
Oramed and Hefei Tianhui form $60m oral insulin JV. Oramed Pharma signed a non-binding term sheet with Hefei Tianhui Biotech to form a JV to commercialize...
2 months ago
Oramed Pharmaceuticals Updates Stock Sale Strategies and Partners - TipRanks.com
Tipranks
Oramed Pharmaceuticals (ORMP) has shared an update. Oramed Pharmaceuticals Inc. has initiated an agreement with Rodman & Renshaw LLC and...
1 month ago
BML Capital Management LLC Purchases 480267 Shares of Oramed Pharmaceuticals Inc. (NASDAQ:ORMP)
Defense World
Read BML Capital Management LLC Purchases 480267 Shares of Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) at Defense World.
1 week ago
Further weakness as Oramed Pharmaceuticals (NASDAQ:ORMP) drops 11% this week, taking one-year losses to 71%
Simply Wall Street
Further weakness as Oramed Pharmaceuticals (NASDAQ:ORMP) drops 11% this week, taking one-year losses to 71% ... Even the best investor on earth...
6 months ago